학술논문
Efficacy and safety of first-line necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin in East Asian patients with stage IV squamous non-small cell lung cancer: A subgroup analysis of the phase 3, open-label, randomized SQUIRE study
Document Type
Article
Author
Source
In: Cancer Research and Treatment . (Cancer Research and Treatment, 2017, 49(4):937-946)
Subject
Language
English
ISSN
20059256
15982998
15982998